3D-Printed Titanium Custom-Made Prostheses in Reconstruction after Pelvic Tumor Resection: Indications and Results in a Series of 14 Patients at 42 Months of Average Follow-Up.
additive manufacturing
custom-made prosthesis
pelvic reconstruction
pelvic tumors
wide resection
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 Aug 2021
12 Aug 2021
Historique:
received:
02
06
2021
revised:
25
07
2021
accepted:
10
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Wide resection is currently considered the mainstay treatment for primary bone tumors. When the tumor is located in anatomically complex segments, 3D-Printed Titanium Custom-Made Prostheses (3DPTCMP) are possible reconstructive solutions. The aim of the present paper is to analyze indications, results and complications of a series of 14 patients who underwent pelvis reconstruction with 3DPTCMP after tumor removal from January 2015 to December 2019. Chondrosarcoma was the main histology; indications were tumors located in the acetabular area without enough residual bone to support a cup with an iliac stem, and tumors located near the sacrum-iliac joint. The margins were wide in 12 cases, and marginal and intralesional in one case each. In three cases, resection also included the sacrum-iliac joint, so a spine stabilization was performed and linked to the pelvic prosthesis; The average MSTS score was 46.3%; the 5-year local recurrence-free survival was 85.7%. Wound dehiscences were the main complication, resolved with multiple debridements; nevertheless, prosthesis removal was necessary in one case. Currently, the 3DPTCMP is an effective resource for reconstruction after resection of tumors located in the pelvis. Further studies are necessary to value long-term results; more strategies are necessary to try to reduce the infection rate and improve osteointegration.
Identifiants
pubmed: 34441834
pii: jcm10163539
doi: 10.3390/jcm10163539
pmc: PMC8397106
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Plast Surg. 2006 Aug;57(2):184-9
pubmed: 16862000
Eur J Surg Oncol. 2013 Jan;39(1):53-60
pubmed: 23131428
Eur J Orthop Surg Traumatol. 2021 Feb 5;:
pubmed: 33547509
Int J Surg. 2016 Dec;36(Pt A):283-292
pubmed: 27840310
J Bone Joint Surg Am. 2020 Sep 2;102(17):1530-1541
pubmed: 32427766
Bone Joint Res. 2018 Nov 3;7(10):570-579
pubmed: 30464837
J Arthroplasty. 2011 Dec;26(8):1508-13
pubmed: 21477973
Clin Orthop Relat Res. 2001 Jul;(388):178-86
pubmed: 11451117
Int Orthop. 2018 Mar;42(3):687-694
pubmed: 28956108
Curr Treat Options Oncol. 2014 Sep;15(3):482-92
pubmed: 24760406
J Bone Joint Surg Am. 1978 Sep;60(6):731-46
pubmed: 701308
ScientificWorldJournal. 2014 Jan 27;2014:605019
pubmed: 24616637
Acta Orthop. 2020 Aug;91(4):489-496
pubmed: 32396448
Arch Orthop Trauma Surg. 2018 Jul;138(7):929-937
pubmed: 29633075
Recent Results Cancer Res. 2009;179:39-50
pubmed: 19230533
Orthopade. 2019 Sep;48(9):752-759
pubmed: 31444515
Plast Reconstr Surg. 2011 Feb;127(2):677-688
pubmed: 21285772
Bone Joint J. 2014 Oct;96-B(10):1404-10
pubmed: 25274929
Bone Joint J. 2017 Feb;99-B(2):267-275
pubmed: 28148672
Nat Rev Urol. 2018 Aug;15(8):511-521
pubmed: 29904105
J Bone Oncol. 2019 Mar 27;16:100234
pubmed: 31011523
J Bone Joint Surg Br. 2012 Jul;94(7):982-8
pubmed: 22733957
Int Orthop. 2019 Jan;43(1):123-132
pubmed: 30467646
Plast Reconstr Surg. 2008 Jul;122(1):171-177
pubmed: 18594402
J Bone Joint Surg Am. 1997 Nov;79(11):1663-74
pubmed: 9384426
J Bone Oncol. 2019 Jan 25;16:100220
pubmed: 31044134
Clin Orthop Relat Res. 1993 Jan;(286):241-6
pubmed: 8425352
J Orthop Sci. 2000;5(3):198-204
pubmed: 10982657
Clin Orthop Relat Res. 2004 Mar;(420):239-50
pubmed: 15057104
Clin Orthop Relat Res. 2002 Apr;(397):29-35
pubmed: 11953592